Fill Out Your Profile to share more about you. Learn more...

Enhertu Way More Effective Than Kadcyla as 2nd Tx for HER2+ MBC

moderators Posts: 8,285

Enhertu Dramatically More Effective Than Kadcyla as Second Treatment for Metastatic HER2-Positive Breast Cancer
September 22, 2021

Enhertu more than doubled the 12-month progression-free survival rate than Kadcyla in people diagnosed with metastatic HER2-positive breast cancer that had been previously treated. Read more...